These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 28770899)

  • 1. Outcome of focal treatment to residual retinoblastoma after chemotherapy (Experience with Focal Treatment of Retinoblastoma).
    Kashif S; Muhammad K; Siyal N; Adhi MI
    J Pak Med Assoc; 2017 Jul; 67(7):1109-1115. PubMed ID: 28770899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation.
    Shields CL; Honavar SG; Meadows AT; Shields JA; Demirci H; Singh A; Friedman DL; Naduvilath TJ
    Am J Ophthalmol; 2002 May; 133(5):657-64. PubMed ID: 11992863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macular retinoblastoma: evaluation of tumor control, local complications, and visual outcomes for eyes treated with chemotherapy and repetitive foveal laser ablation.
    Schefler AC; Cicciarelli N; Feuer W; Toledano S; Murray TG
    Ophthalmology; 2007 Jan; 114(1):162-9. PubMed ID: 17070578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect on ocular survival of adding early intensive focal treatments to a two-drug chemotherapy regimen in patients with retinoblastoma.
    Wilson MW; Haik BG; Liu T; Merchant TE; Rodriguez-Galindo C
    Am J Ophthalmol; 2005 Sep; 140(3):397-406. PubMed ID: 16138999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.
    Gündüz K; Günalp I; Yalçindağ N; Unal E; Taçyildiz N; Erden E; Geyik PO
    Ophthalmology; 2004 Oct; 111(10):1917-24. PubMed ID: 15465557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Results of combined chemotherapy and local ophtalmic therapy of children with intraocular retinoblastoma].
    Balwierz W; Kobylarz J; Starzycka M; Dluzniewska A
    Med Wieku Rozwoj; 2001; 5(3 Suppl 1):15-23. PubMed ID: 12004148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management and outcome of retinoblastoma with vitreous seeds.
    Manjandavida FP; Honavar SG; Reddy VA; Khanna R
    Ophthalmology; 2014 Feb; 121(2):517-24. PubMed ID: 24572675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thermochemotherapy in hereditary retinoblastoma.
    Schueler AO; Jurklies C; Heimann H; Wieland R; Havers W; Bornfeld N
    Br J Ophthalmol; 2003 Jan; 87(1):90-5. PubMed ID: 12488270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemoreduction for unilateral retinoblastoma.
    Shields CL; Honavar SG; Meadows AT; Shields JA; Demirci H; Naduvilath TJ
    Arch Ophthalmol; 2002 Dec; 120(12):1653-8. PubMed ID: 12470138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined chemotherapy and local treatment in the management of intraocular retinoblastoma.
    Brichard B; De Bruycker JJ; De Potter P; Neven B; Vermylen C; Cornu G
    Med Pediatr Oncol; 2002 Jun; 38(6):411-5. PubMed ID: 11984802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of induction chemotherapy in retinoblastoma, alone or combined with other adjuvant modalities.
    Ghose S; Nizamuddin SH; Sethi A; Mohanti BK; Kumar H; Arya LS; Thavaraj V
    J Pediatr Ophthalmol Strabismus; 2002; 39(3):143-50. PubMed ID: 12051279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The outcome of chemoreduction treatment in patients with Reese-Ellsworth group V retinoblastoma.
    Gündüz K; Shields CL; Shields JA; Meadows AT; Gross N; Cater J; Needle M
    Arch Ophthalmol; 1998 Dec; 116(12):1613-7. PubMed ID: 9869790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of a two-drug chemotherapy regimen for intraocular retinoblastoma.
    Zage PE; Reitman AJ; Seshadri R; Weinstein JL; Mets MB; Zeid JL; Greenwald MJ; Strauss LC; Goldman S
    Pediatr Blood Cancer; 2008 Mar; 50(3):567-72. PubMed ID: 17729249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy plus local treatment in the management of intraocular retinoblastoma.
    Murphree AL; Villablanca JG; Deegan WF; Sato JK; Malogolowkin M; Fisher A; Parker R; Reed E; Gomer CJ
    Arch Ophthalmol; 1996 Nov; 114(11):1348-56. PubMed ID: 8906025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macular retinoblastoma managed with chemoreduction: analysis of tumor control with or without adjuvant thermotherapy in 68 tumors.
    Shields CL; Mashayekhi A; Cater J; Shelil A; Ness S; Meadows AT; Shields JA
    Arch Ophthalmol; 2005 Jun; 123(6):765-73. PubMed ID: 15955977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 10-year experience of outcome in chemotherapy-treated hereditary retinoblastoma.
    Bartuma K; Pal N; Kosek S; Holm S; All-Ericsson C
    Acta Ophthalmol; 2014 Aug; 92(5):404-11. PubMed ID: 24119165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Globe conserving treatment of the only eye in bilateral retinoblastoma.
    Lee V; Hungerford JL; Bunce C; Ahmed F; Kingston JE; Plowman PN
    Br J Ophthalmol; 2003 Nov; 87(11):1374-80. PubMed ID: 14609838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemoreduction and local ophthalmic therapy for intraocular retinoblastoma.
    Friedman DL; Himelstein B; Shields CL; Shields JA; Needle M; Miller D; Bunin GR; Meadows AT
    J Clin Oncol; 2000 Jan; 18(1):12-7. PubMed ID: 10623688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiagent chemotherapy as neoadjuvant treatment for multifocal intraocular retinoblastoma.
    Wilson MW; Rodriguez-Galindo C; Haik BG; Moshfeghi DM; Merchant TE; Pratt CB
    Ophthalmology; 2001 Nov; 108(11):2106-14; discussion 2114-5. PubMed ID: 11713087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoreduction for group E retinoblastoma: comparison of chemoreduction alone versus chemoreduction plus low-dose external radiotherapy in 76 eyes.
    Shields CL; Ramasubramanian A; Thangappan A; Hartzell K; Leahey A; Meadows AT; Shields JA
    Ophthalmology; 2009 Mar; 116(3):544-551.e1. PubMed ID: 19157557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.